Prostate cancer has been of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...
Bayer AG (BAYRY) announced an update on their ongoing clinical study.
The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...
(WXYZ) — In today's health alert, the second leading cause of cancer-related deaths among men worldwide may soon have a promising new treatment. Biontech has ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
MedPage Today on MSN
Similar Prostate Cancer Drugs Show Different Results in Real-World Study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision-guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
Many Black men are not given the novel hormone therapies that have become a game changer in the treatment of people with advanced prostate cancer. Recent advances in treatment, notably the new hormone ...
Former President Joe Biden's advanced prostate cancer diagnosis has left Fox News senior medical analyst Dr. Marc Siegel "absolutely shocked" by the timing. "It has to get really pretty far advanced ...
Despite his age and an ominous-sounding disease, former President Joe Biden has reason for optimism about his aggressive prostate cancer diagnosis, announced over the weekend. According to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results